it is unusual to see a 20% decline and then someone on the scientific advisory board leaving immediately after what is, on the surface, really the best outcome for the clinical results that we could've asked for. But looking at what he is involved with, Leigh looks pretty busy and maybe he didn't like the 2x strikes on the remuneration report.
i wonder what will happen if P2B results are good by easter, maybe we go to 15c?
ILA Price at posting:
18.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)